News > Eli Lilly’s Antibody Treatment Gets Emergency F.D.A. Approval

Eli Lilly’s Antibody Treatment Gets Emergency F.D.A. Approval

The Food and Drug Administration has granted emergency authorization of a Covid-19 antibody treatment made by Eli Lilly that is similar to a therapy given to President Trump shortly after he contracted the coronavirus.

The decision is likely to be seen as a valuable tool to treat patients with Covid-19 at a time when the pandemic is raging across the United States, hospitals are overwhelmed and doctors have few options to treat the disease.